Coherus BioSciences
CHRS
#10164
Rank
ยฃ43.68 M
Marketcap
ยฃ0.28
Share price
-4.47%
Change (1 day)
-68.09%
Change (1 year)

Earnings for Coherus BioSciences (CHRS)

Earnings in 2026 (TTM): -ยฃ0.12 Billion

According to Coherus BioSciences 's latest financial reports the company's current earnings are ยฃ50.93 Million. In 2025 the company made an earning of -ยฃ0.14 Billion, an increase over its 2024 earnings that were of -ยฃ0.16 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Coherus BioSciences from 2014 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ0.12 Billion-14.52%
2025 -ยฃ0.14 Billion-15.4%
2024 -ยฃ0.16 Billion4.1%
2023 -ยฃ0.16 Billion-23.74%
2022 -ยฃ0.2 Billion-1.84%
2021 -ยฃ0.21 Billion-268.38%
2020 ยฃ0.11 B42.13%
2019 ยฃ84.37 M-155.26%
2018 -ยฃ0.16 Billion-12.68%
2017 -ยฃ0.18 Billion90.92%
2016 -ยฃ91.59 Million-46.49%
2015 -ยฃ0.18 Billion168.87%
2014 -ยฃ63.66 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
ยฃ8.44 B-7,368.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
ยฃ23.45 M-120.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-ยฃ0.21 Billion 78.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
-ยฃ0.48 Billion 312.28%๐Ÿ‡บ๐Ÿ‡ธ USA